Sucampo Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance
May 3, 2017 6:37 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q1 EPS of $0.10, $0.17 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $56.3 million versus the consensus estimate of $54.14 million.
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo expects total revenue of... More
